Skip to content

Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening

Comparison of Explicit Values Clarification Method (VCM), Implicit VCM and no VCM Decision Aids for Men Considering Prostate Cancer Screening: Protocol of a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03988673
Enrollment
276
Registered
2019-06-17
Start date
2019-09-30
Completion date
2020-09-30
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The investigators aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM. This study will add to the body of evidence on the role of decision aids to support health preference-sensitive choices and provide further insight on the impact of different methods for eliciting people's values embedded within a decision aid.

Detailed description

PSA test to screen for prostate cancer is considered a preference sensitive decision, meaning it does not only depend on what is best from a medical point of view, but also on patient values. Decision aids are evidence-based tools which showed to help people feel clearer about their values, therefore it has been advocated that decision aids should contain a specific values clarification method (VCM). VCM may be either implicit or explicit but the evidence concerning the best method is scarce. We aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM.

Interventions

OTHERDecision aid with implicit values clarification method (booklet or website)

The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a grid where statements about the subject will be presented (decision aid with implicit VCM).

OTHERDecision aid with explicit values clarification method (booklet or website)

The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a a grid where statements about the subject will be presented and men should indicate what statements they identify with (decision aid with explicit VCM).

Sponsors

NOVA Medical School
CollaboratorOTHER
Georgetown University
CollaboratorOTHER
Universidade do Porto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Parallel three group (1:1:1): (i) decision aid with information only (Control), (ii) decision aid with information plus an implicit VCM, (iii) decision aid with information plus an explicit VCM.

Eligibility

Sex/Gender
MALE
Age
50 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* adult men (50 - 69 years); * men with average risk for prostate cancer; * willing and able to provide written informed consent.

Exclusion criteria

* unable to understand written Portuguese.

Design outcomes

Primary

MeasureTime frameDescription
Perceived clarity of personal valuesimmediately after the intervention3-item subscale of the Decisional Conflict Scale. Items are given a score of 0 (strongly agree) to 4 (strongly disagree). Items are: a) summed; b) divided 3; and c) multiplied by 25. Scores range from 0 \[feels extremely clear about personal values\] to 100 \[feels extremely unclear about personal values\].

Secondary

MeasureTime frameDescription
Decisional Conflictimmediately after the interventionDecisional Conflict Scale (16-item). Items are given a score of 0 (strongly agree) to 4 (strongly disagree). Items are: a) summed; b) divided 16; and c) multiplied by 25. Scores range from 0 \[no decisional conflict\] to 100 \[extremely high decisional conflict\].
% of patients with preference to undergo PSA screening (screening intention; questionnaire)before and immediately after the interventionIntention to undergo prostate cancer screening with PSA: questionnaire - single question about intention to be screened with PSA, using a 5 point-Likert scale (ranging from strongly disagree to strongly agree; intention to undergo PSA screening will be considered positive if the respondent replies with agree or strongly agree). % of patients with preference to undergo PSA screening.
% of patients who underwent PSA screening (questionnaire)6 months after the interventionSelf-reported PSA screening. Questionnaire - single question. Men will report wether they have or have not underwent PSA screening after the intervention. % of patients who underwent PSA screening

Contacts

Primary ContactSofia Baptista, MD
sofiatbaptista@gmail.com00351910357362
Backup ContactAntónio Soares, PhD
ajasoares@cintesis.eu00351225513622

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026